Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10246514
Single domain antibodies that bind to human CD20
granted -
US 10246709
Targeting ligands for therapeutic compounds
granted -
US 10246708
Dosages and methods for delivering lipid formulated nucleic acid molecules
granted -
US 10246509
Restricted immunoglobulin heavy chain mice
granted -
US 10246505
Chimeric antigen receptors to control HIV infection
granted -
US 10246471
ETP derivatives
granted -
US 10246453
Benzenesulfonamide compounds and their use as therapeutic agents
granted -
IT 201700108526
COMPOSIZIONI ORALI PER IL TRATTAMENTO DEL REFLUSO GASTROESOFAGEO.
granted -
US 10239911
Beta-D-2′-deoxy-2′-alpha-fluoro-2′-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 10238652
Compounds for treatment of cancer
granted -
US 10238698
Biomarkers and combination therapies using oncolytic virus and immunomodulation
granted -
US 10240130
CDNA clone-launched platform for high-yield production of inactivated zika virus
granted -
US 10239832
N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors
granted -
US 10238710
Peptide having anti-inflammatory, osteogenic and hair growth promoting activities, and use of same
granted -
US 10240157
Diagnostic and screening methods for atopic dermatitis
granted -
US 10240152
Compositions and methods for inhibiting expression of transthyretin
granted -
US 10240153
Organic compositions to treat APOC3-related diseases
granted -
US 10240149
Reduced size self-delivering RNAi compounds
granted -
US 10239954
Antibodies specific for urokinase-type plasminogen activator and methods of use thereof for treating cancer
granted -
US 10239949
Oncofetal antigen binding proteins and related compositions and methods
granted -
US 10239912
Modulators of 5′-nucleotidase, ecto and the use thereof
granted -
US 10239918
Cahuitamycins and methods of making and using the same
granted -
US 10238770
Reparative cell isolation and delivery
granted -
US 10239837
Piperidine derivatives as HDAC1/2 inhibitors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.